{
  "docId": "019de076-9336-7344-93bc-154185328b25",
  "docSlug": "edea36d6b00ed662cafb2da1a03c41ae",
  "documentTitle": "BenevolentAI | Investor Conference Presentation Deck | 22 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 22,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "other",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de076-9336-7344-93bc-154185328b25/5",
  "deckHref": "/decks/019de076-9336-7344-93bc-154185328b25",
  "deckJsonHref": "/decks/019de076-9336-7344-93bc-154185328b25.json",
  "deckAnchorHref": "/decks/019de076-9336-7344-93bc-154185328b25#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.28,
        "x": 0.08,
        "y": 0.07
      },
      "kind": "image",
      "text": "AstraZeneca logo",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "78516dc2-211e-4001-93a6-9bc7358ea1cd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.5,
        "x": 0.43,
        "y": 0.28
      },
      "kind": "list",
      "text": "Multi-year Target-ID collaboration delivering novel targets for complex diseases. Deal structure of upfront fee, milestone payments and downstream royalties. AZ progressing four most promising targets. Further target selection opportunities in Heart Failure and SLE.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "62cd9867-0efd-4030-8030-ecb446b75b02",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.38,
        "x": 0.03,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "THERAPEUTIC AREAS: 2019 - INITIAL DEAL (CKD, IPF); 2022 - EXPANSION (Heart failure, SLE). RECENT POSITIVE DEVELOPMENTS: May 2023 New preclinical data on one of the IPF targets presented by AZ at American Thoracic Society (ATS).",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "669f5fe6-dee2-4aac-8e43-bd8991e2e759",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.5,
        "x": 0.43,
        "y": 0.1
      },
      "kind": "title",
      "text": "Collaboration with AstraZeneca continues to progress",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3154dfff-4f78-4615-ad7c-90f3bcc37c91",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "748221b8-8f1b-49c8-b44b-5b6f77a67ba5",
      "evidence": "THERAPEUTIC AREAS: 2019 - INITIAL DEAL (CKD, IPF); 2022 - EXPANSION (Heart failure, SLE)",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 6,
      "from": 5,
      "beatId": "5e794bc6-a251-4149-a985-6241ead7f855",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "Slides on strategic collaborations and pipeline products showcase the solution.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 3,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "0a7dc950-f012-4806-a974-ccc12cfbaec1",
      "evidence": "The presentation emphasizes the potential of the Benevolent Platform™.",
      "position": 0,
      "objective": "Highlighting the importance of AI-driven drug discovery",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}